WEARABLE INJECTOR MARKET ANALYSIS
Increasing prevalence of chronic diseases and high demand for advanced drug delivery device for frequent administration of drug is expected to augment the market growth
According to the World Health Organization (WHO), around 1.6 million deaths caused by diabetes in 2015 and is expected to increase by more than 50% before the age of 70 years by 2030. Moreover, According to National Institute of Health (NIH), in 2017, around 23.5 million people are suffering from autoimmune diseases in U.S.
According to World Health Organization (WHO), in 2017, nearly 1 in every 6 death occurs due to cancer globally and approximately 70% of deaths from cancer occur in low and middle-income countries. Increasing prevalence of chronic disease and high demand for advanced drug delivery devices for frequent administration of drugs is expected to fuel the growth of wearable injector market during the forecast period.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 